Announcements Trials
Browse Landscape

Status

Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 449Stomach Neoplasms 295Rectal Neoplasms 271Colonic Neoplasms 192Pancreatic Neoplasms 175Neoplasm Metastasis 110Esophageal Neoplasms 88Neoplasms 68Carcinoma, Hepatocellular 60Adenocarcinoma Of Esophagus 47Adenocarcinoma 46Cholangiocarcinoma 45Lymphoma, Large B-Cell, Diffuse 44Carcinoma, Non-Small-Cell Lung 41Biliary Tract Neoplasms 38Gallbladder Neoplasms 31Gastrointestinal Neoplasms 29Recurrence 25Liver Neoplasms 25Ovarian Neoplasms 23Esophageal Squamous Cell Carcinoma 23Breast Neoplasms 22Peritoneal Neoplasms 18Bile Duct Neoplasms 17Unspecified Adult Solid Tumor, Protocol Specific 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Locally Advanced Rectal Cancer 13Head and Neck Neoplasms 13Lung Neoplasms 12Lymphoma, Non-Hodgkin 11

Interventions

Morphine 2ziconotide 1rimabotulinumtoxinB 1Syringes 1Psilocybin 1Plastic Surgery Procedures 1Oxaliplatin 1Massage 1Low-Level Light Therapy 1Lidocaine 1Leucovorin 1Gels 1Fluorouracil 1Ethanol 1Erythromycin 1Botulinum Toxins, Type A 1Bandages 1Bacitracin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wounds and Injuries × Oxaliplatin × Clear all
NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Sun Yat-sen University

Approved for marketing
Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡